162 related articles for article (PubMed ID: 22737255)
1. Cross-regulation of protein stability by p53 and nuclear receptor SHP.
Yang Z; Zhang Y; Kemper JK; Wang L
PLoS One; 2012; 7(6):e39789. PubMed ID: 22737255
[TBL] [Abstract][Full Text] [Related]
2. An autoregulatory feedback loop between Mdm2 and SHP that fine tunes Mdm2 and SHP stability.
Yang Z; Wang L
FEBS Lett; 2012 Apr; 586(8):1135-40. PubMed ID: 22575647
[TBL] [Abstract][Full Text] [Related]
3. Mdm2 is a novel activator of ApoCIII promoter which is antagonized by p53 and SHP inhibition.
Yang Z; Zhang Y; Wang L
Biochem Biophys Res Commun; 2012 Jan; 417(2):744-6. PubMed ID: 22197810
[TBL] [Abstract][Full Text] [Related]
4. Oligomerization conditions Mdm2-mediated efficient p53 polyubiquitylation but not its proteasomal degradation.
Hjerpe R; Aillet F; Lopitz-Otsoa F; Lang V; Torres-Ramos M; Farrás R; Hay RT; Rodríguez MS
Int J Biochem Cell Biol; 2010 May; 42(5):725-35. PubMed ID: 20080206
[TBL] [Abstract][Full Text] [Related]
5. Targeted inactivation of Mdm2 RING finger E3 ubiquitin ligase activity in the mouse reveals mechanistic insights into p53 regulation.
Itahana K; Mao H; Jin A; Itahana Y; Clegg HV; Lindström MS; Bhat KP; Godfrey VL; Evan GI; Zhang Y
Cancer Cell; 2007 Oct; 12(4):355-66. PubMed ID: 17936560
[TBL] [Abstract][Full Text] [Related]
6. The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop.
Lu X; Ma O; Nguyen TA; Jones SN; Oren M; Donehower LA
Cancer Cell; 2007 Oct; 12(4):342-54. PubMed ID: 17936559
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the MDM2-p53 pathway by ribosomal protein L11 involves a post-ubiquitination mechanism.
Dai MS; Shi D; Jin Y; Sun XX; Zhang Y; Grossman SR; Lu H
J Biol Chem; 2006 Aug; 281(34):24304-13. PubMed ID: 16803902
[TBL] [Abstract][Full Text] [Related]
8. Wild-type and cancer-related p53 proteins are preferentially degraded by MDM2 as dimers rather than tetramers.
Katz C; Low-Calle AM; Choe JH; Laptenko O; Tong D; Joseph-Chowdhury JN; Garofalo F; Zhu Y; Friedler A; Prives C
Genes Dev; 2018 Mar; 32(5-6):430-447. PubMed ID: 29549180
[TBL] [Abstract][Full Text] [Related]
9. Controlled access of p53 to the nucleus regulates its proteasomal degradation by MDM2.
Davis JR; Mossalam M; Lim CS
Mol Pharm; 2013 Apr; 10(4):1340-9. PubMed ID: 23398638
[TBL] [Abstract][Full Text] [Related]
10. Modulation of p53 degradation via MDM2-mediated ubiquitylation and the ubiquitin-proteasome system during reperfusion after stroke: role of oxidative stress.
Saito A; Hayashi T; Okuno S; Nishi T; Chan PH
J Cereb Blood Flow Metab; 2005 Feb; 25(2):267-80. PubMed ID: 15678128
[TBL] [Abstract][Full Text] [Related]
11. The p53 paddy wagon: COP1, Pirh2 and MDM2 are found resisting apoptosis and growth arrest.
Corcoran CA; Huang Y; Sheikh MS
Cancer Biol Ther; 2004 Aug; 3(8):721-5. PubMed ID: 15280670
[TBL] [Abstract][Full Text] [Related]
12. DNA damage-induced phosphorylation of MdmX at serine 367 activates p53 by targeting MdmX for Mdm2-dependent degradation.
Okamoto K; Kashima K; Pereg Y; Ishida M; Yamazaki S; Nota A; Teunisse A; Migliorini D; Kitabayashi I; Marine JC; Prives C; Shiloh Y; Jochemsen AG; Taya Y
Mol Cell Biol; 2005 Nov; 25(21):9608-20. PubMed ID: 16227609
[TBL] [Abstract][Full Text] [Related]
13. Dynamics in the p53-Mdm2 ubiquitination pathway.
Brooks CL; Gu W
Cell Cycle; 2004 Jul; 3(7):895-9. PubMed ID: 15254415
[TBL] [Abstract][Full Text] [Related]
14. Stabilization of p53 by CP-31398 inhibits ubiquitination without altering phosphorylation at serine 15 or 20 or MDM2 binding.
Wang W; Takimoto R; Rastinejad F; El-Deiry WS
Mol Cell Biol; 2003 Mar; 23(6):2171-81. PubMed ID: 12612087
[TBL] [Abstract][Full Text] [Related]
15. Retinoblastoma protein modulates gankyrin-MDM2 in regulation of p53 stability and chemosensitivity in cancer cells.
Qiu W; Wu J; Walsh EM; Zhang Y; Chen CY; Fujita J; Xiao ZX
Oncogene; 2008 Jul; 27(29):4034-43. PubMed ID: 18332869
[TBL] [Abstract][Full Text] [Related]
16. Prolyl hydroxylase 3 stabilizes the p53 tumor suppressor by inhibiting the p53-MDM2 interaction in a hydroxylase-independent manner.
Xu Y; Gao Q; Xue Y; Li X; Xu L; Li C; Qin Y; Fang J
J Biol Chem; 2019 Jun; 294(25):9949-9958. PubMed ID: 31092600
[TBL] [Abstract][Full Text] [Related]
17. HAUSP-nucleolin interaction is regulated by p53-Mdm2 complex in response to DNA damage response.
Lim KH; Park JJ; Gu BH; Kim JO; Park SG; Baek KH
Sci Rep; 2015 Aug; 5():12793. PubMed ID: 26238070
[TBL] [Abstract][Full Text] [Related]
18. p53 Promotes proteasome-dependent degradation of oncogenic protein HBx by transcription of MDM2.
Xian L; Zhao J; Wang J; Fang Z; Peng B; Wang W; Ji X; Yu L
Mol Biol Rep; 2010 Jul; 37(6):2935-40. PubMed ID: 19842060
[TBL] [Abstract][Full Text] [Related]
19. ATM activates p53 by regulating MDM2 oligomerization and E3 processivity.
Cheng Q; Chen L; Li Z; Lane WS; Chen J
EMBO J; 2009 Dec; 28(24):3857-67. PubMed ID: 19816404
[TBL] [Abstract][Full Text] [Related]
20. Mdm2 facilitates the association of p53 with the proteasome.
Kulikov R; Letienne J; Kaur M; Grossman SR; Arts J; Blattner C
Proc Natl Acad Sci U S A; 2010 Jun; 107(22):10038-43. PubMed ID: 20479273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
